MedPath

The Female Health Dietary Intervention Study

Not Applicable
Completed
Conditions
Polycystic Ovary Syndrome
Morbid Obesity
Interventions
Behavioral: Crispbread
Registration Number
NCT00779571
Lead Sponsor
The Hospital of Vestfold
Brief Summary

This study has two phases:

1. In phase 1 of the study (8 weeks),the effect of two different low calorie diets on manifestations of PCOS, including risk factors for the metabolic syndrome and cardiovascular risk profile will be compared.

2. In phase 2 the long term effect (next 44 weeks) on sustained weight-loss and the above mentioned parameters will be compared and evaluated.

Detailed Description

Weight loss is an important and effective treatment of morbidly obese women with PCOS. Effective weight reduction will improve manifestations of PCOS and risk factors for developing type 2 diabetes and coronary heart diseases. We compare the effect of two isocaloric low calorie diets (LCD), - one powder-based shake-diet and a fiber rich diet on the above mentioned parameters. In addition we want to compare the weight-maintenance effect the next 44 weeks of two different follow-up programs: A usual care- and a lifestyle-program.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
61
Inclusion Criteria
  • Woman (European Caucasian)
  • PCOS
  • BMI = or > 35
Exclusion Criteria
  • Cushing syndrome
  • Adrenal hyperplasia
  • Androgen-producing tumors
  • Anovulation caused by hyperprolactinemia
  • Pregnancy, breast feeding
  • Use of oral contraceptives/hormone treatment/insulin-sensitizing agents

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CrispbreadCrispbreadIntervention: Crispbread LCD
Liquid meal replacementCrispbreadIntervention: LMR LCD
Primary Outcome Measures
NameTimeMethod
Weight lossOne year
Secondary Outcome Measures
NameTimeMethod
Improvement of PCOS, diabetes type 2- and coronary heart disease-risk factorsone year

Trial Locations

Locations (1)

Kvinneklinikken, Rikshospitalet-Radiumhospitalet HF

🇳🇴

Oslo, Norway

© Copyright 2025. All Rights Reserved by MedPath